NOTMAN DONALD (Chief Financial Officer) sold 3.0% of their position (11.49K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $101.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/4/2026ACC: 0001104659-26-010462
Officer· Chief Financial Officer
Since Aug 2018
-11.49K
Net shares
Net seller
$101.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
11.49K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.46K
Price / share
$9.14
Trade value
$49.86K
% of position
1.4%
2/2/2026
389.29K→383.84K
Common Stock
Direct
Shares
−6.04K
Price / share
$8.54
Trade value
$51.54K
% of position
1.6%
2/4/2026
383.84K→377.80K
Total
Net shares
−11.49K
Net value
-$101.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −5.46K | $9.14 | $49.86K | 1.4% | 389.29K | 383.84K |
| Common Stock Direct | 2/4/2026 | S · Sale | −6.04K | $8.54 | $51.54K | 1.6% | 383.84K | 377.80K |
| Total | −11.49K | -$101.40K | ||||||
Derivative Transactions0
No derivative transactions reported